| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2024―Sep―18 |
The effect of the COVID-19 pandemic on hospitalizations of cirrhotic patients |
G. Sinatti, B. Cosimini, A.A. Braicu, S.Jr. Santini, V. Caputo, A. Ruscitti, L. Mammarella, C. Balsano |
| 2 |
[GO] |
2024―Apr―10 |
T.12.5: MECHANISTIC ANALYSIS OF FACTORS ASSOCIATED WITH POST COVID-19 IBS OCCURRENCE |
K. Hod, G. Marasco, C. Cremon, M.R. Barbaro, L. Colecchia, A. Kagramanova, D. Bordin, V. Drug, P. Fusaroli, S.Y. Mohamed, C. Ricci, M. Bellini, M.M. Rahman, L. Melcarne, J. Santos, S. Bor, S. Yapali, S. Lukic, M. Trajkovska, D. Dumitrascu, A. Pietrangelo, U. Ghoshal, O. Kolokolnikova, A. Colecchia, J. Serra, G. Marconi, S. Danese, P. Portincasa, M. Maggio, E. Philippou, Y.Y. Lee, V. Stanghellini, G. Barbara |
| 3 |
[GO] |
2024―Apr―10 |
T.02.8: PRIORITIZE STUDY: PRIORITIZING RESUMPTION OF COLORECTAL SCREENING AFTER COVID PANDEMIC |
S. Pecere, L. Frazzoni, C. Hassan, L.E. Del Vecchio, C. Fabbri, F. Iacopini, L. Fuccio, A. Repici, C. Spada, C. Senore, G. Antonelli |
| 4 |
[GO] |
2024―Apr―08 |
Corrigendum to “Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review” [Digestive and Liver Disease, Volume 56, Issue 1, January 2024, Pages 1-6] |
Massimo Claudio Fantini, Erica Loddo, Amalia Di Petrillo, Sara Onali |
| 5 |
[GO] |
2024―Jan―21 |
OC.11.4 ITALIAN SOCIETY FOR DIGESTIVE DISEASES ACCREDITATION PROGRAM DURING COVID-19 PANDEMIC: RESULTS IN REMOTE REACCREDITATION IN 15 CENTRES |
G. Spinzi, P. Da Massa Carrara, V. Boarino, P. Brosolo, T. Iannone, A. Merighi, M. Labardi, A. Milano, G. Rando, M. Capelli |
| 6 |
[GO] |
2023―Jun―15 |
Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review |
Massimo Claudio Fantini, Erica Loddo, Amalia Di Petrillo, Sara Onali |
| 7 |
[GO] |
2023―Mrz―23 |
T.01.2 NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING (NVUGIB): HOW DID COVID-19 IMPACT ON HOSPITALIZATIONS AND 30-DAY MORTALITY IN VENETO REGION? |
B. Germana, L. Salmaso, S. Bellio, U. Fedeli, M. Saia |
| 8 |
[GO] |
2023―Mrz―23 |
OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY |
F.S. Macaluso, M. Principi, F. Facciotti, A. Contaldo, A. Todeschini, S. Saibeni, C. Bezzio, F. Castiglione, O. Nardone, R. Spagnuolo, M. Fantini, G. Riguccio, F. Conforti, F. Caprioli, C. Vigano, C. Felice, G. Fiorino, C. Correale, G. Bodini, M. Milla, G. Scardino, M. Vernero, F. Desideri, F. Bossa, M. Guerra, M. Ventimiglia, M. Mannino, G. Rizzo, A. Orlando |
| 9 |
[GO] |
2023―Mrz―23 |
T.03.3 THE INFLUENCE OF SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) LIFESTYLE CHANGES ON NON-ALCOHOLIC FATTY LIVER DISEASE EVOLUTION: A MATTER OF BODY COMPOSITION: A MULTICENTER CLINICAL STUDY |
M. Romeo, M. Cipullo, G. Zagaria, L. Ventriglia, F. Scognamiglio, G. Iadanza, S. Olivieri, A.C. Coppola, M. Dallio, M. Sangineto, G. Serviddio, A. Federico |
| 10 |
[GO] |
2023―Mrz―23 |
OC.14.1 SARS-COV-2 INFECTION DOES NOT WORSEN THE COURSE OF INFLAMMATORY BOWEL DISEASE IN THE LONG TERM |
B. Neri, G. D'Agostini, S. Salvatori, M. Mossa, F. Bettin, I. Marafini, E. Lolli, E. Calabrese, G. Monteleone, L. Biancone |
| 11 |
[GO] |
2023―Mrz―23 |
T.06.7 THE BURDEN OF SARS-COV-2 PANDEMIC ON COLORECTAL CANCER SCREENING PROGRAM DELAY: DATA FROM A LARGE SCREENING CENTRE IN CAMPANIA |
N. Imperatore, G. Cordone, L. Martorelli, M. Avellino, D. Musto, V. Familiari, M.D. Franzese, S. Ricciolino, R. Lamanda |
| 12 |
[GO] |
2023―Mrz―23 |
OC.05.6 HELICOBACTER PYLORI AND SARS-COV-2: A DANGEROUS PATHOGENETIC CORRELATION? |
F. Termite, G. Gasbarrini, S. Simeoni, F. Bonvicini |
| 13 |
[GO] |
2023―Mrz―09 |
Medium-term outcome of liver recipients from COVID-19 donors |
M. Saracco, D. Cocchis, F. Tandoi, F. Rigo, R. Romagnoli, S. Martini |
| 14 |
[GO] |
2023―Mrz―09 |
Omicron SARS-CoV-2 variant outbreak in vaccinated liver transplant (LT) recipients in 2022: A large spread of infection, a mild disease |
M.F. Donato, C. Dibenedetto, E. Farina, A. Toppetta, S.C. Uceda Renteria, C. Rigamonti, B. Antonelli, L. Caccamo, A. Lombardi, A. Bandera, F. Ceriotti, P. Lampertico |
| 15 |
[GO] |
2023―Mrz―03 |
Where are the non-celiac gluten-sensitive patients gone? The COVID-19 effect |
Carolina Ciacci, Francesco Valitutti |
| 16 |
[GO] |
2023―Jan―17 |
The natural history of COVID-19 in vaccinated inflammatory bowel disease patients |
N. Viazis, I. Drygiannakis, K. Karmiris, A. Theodoropoulou, E. Zampeli, M. Tzouvala, G. Bamias, C. Liatsos, G. Theocharis, S. Vrakas, E. Tsironi, N. Mathou, A. Mantaka, A. Christidou, K. Koustenis, Ch. Veretanos, E. Papathanasiou, E. Zacharopoulou, G. Tribonias, V. Kitsou, S. Kartsoli, A. Theodoulou, S. Michopoulos, K. Thomopoulos, I.E. Koutroubakis, G.J. Mantzaris |
| 17 |
[GO] |
2023―Jan―16 |
Biodegradable biliopancreatic stents could help conserve health care resources during the COVID-19 pandemic: An observational multicenter study |
Andreas Maieron, Lukas Erhart, Patricia Pramhofer, Rainer Schöfl, Georg Spaun, Emanuel Steiner, Friedrich Wewalka, Alexander Ziachehabi |
| 18 |
[GO] |
2023―Jan―05 |
Multiple benefits of implementing a hepatology rapid access clinic highlighted by the COVID-19 pandemic |
Mirela Chitul, Ji Jade King, Andrei Chitul, Paul Balanescu, Aruna Dias |
| 19 |
[GO] |
2022―Dez―16 |
COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalization |
Tommaso Stroffolini, Alessia Ciancio, Alessandro Federico, Rosa G. Benigno, Guido Colloredo, Anna Lombardi, Grazia Anna Niro, Gabriella Verucchi, Luigina Ferrigno, Federico Gioli, Massimo Marignani |
| 20 |
[GO] |
2022―Nov―26 |
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis |
Amnuay Keebayoon, Viroj Wiwanitkit |
| 21 |
[GO] |
2022―Okt―29 |
Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease” |
Fabio Salvatore Macaluso, Ambrogio Orlando |
| 22 |
[GO] |
2022―Okt―18 |
Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study” |
Pathum Sookaromdee, Viroj Wiwanitkit |
| 23 |
[GO] |
2022―Okt―17 |
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study |
Massimo Iavarone, Giulia Tosetti, Floriana Facchetti, Matilde Topa, Joey Ming Er, Shou Kit Hang, Debora Licari, Andrea Lombardi, Roberta D'Ambrosio, Elisabetta Degasperi, Alessandro Loglio, Chiara Oggioni, Riccardo Perbellini, Riccardo Caccia, Alessandra Bandera, Andrea Gori, Ferruccio Ceriotti, Luigia Scudeller, Antonio Bertoletti, Pietro Lampertico |
| 24 |
[GO] |
2022―Okt―10 |
Artificial intelligence and big data processing for the development of predictive models to support Covid-19 hospital patients |
L. Miele, M. Dajko, M.C. Savino, V. Calvez, N.D. Capocchiano, A. Liguori, G. Marrone, M. Biolato, S. Patarnello, A. Gasbarrini, A. Grieco |
| 25 |
[GO] |
2022―Sep―29 |
Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States |
Donghee Kim, Omar Alshuwaykh, Brittany B. Dennis, George Cholankeril, Joshua W. Knowles, Aijaz Ahmed |
| 26 |
[GO] |
2022―Sep―06 |
Intentional Treatment with Tofacitinib in a patient with severe refractory Ulcerative Colitis and concomitant Sars-CoV-2 infection |
Stefano Festa, Fabiola De Biasio, Annalisa Aratari, Claudio Papi |
| 27 |
[GO] |
2022―Aug―29 |
Reduced Humoral Response to Two Doses of COVID-19 Vaccine in Patients with Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD study |
Fabio Salvatore Macaluso, Mariabeatrice Principi, Federica Facciotti, Antonella Contaldo, Alessia Todeschini, Simone Saibeni, Cristina Bezzio, Fabiana Castiglione, Olga Maria Nardone, Rocco Spagnuolo, Massimo Claudio Fantini, Gaia Riguccio, Flavio Caprioli, Chiara Viganò, Carla Felice, Gionata Fiorino, Carmen Correale, Giorgia Bodini, Monica Milla, Giulia Scardino, Marta Vernero, Federico Desideri, Mariella Mannino, Giuseppe Rizzo, Ambrogio Orlando, Arnaldo Amato, Marta Ascolani, Giulio Calabrese, Angelo Casà, Michele Comberlato, Francesco Simone Conforti, Manuela De Bona, Maria Giulia Demarzo, Patrizia Doldo, Gabriele Dragoni, Federica Furfaro, Giacomo Mulinacci, Oriana Olmo, Nicole Piazza O'Sed, Salvatore Paba, Simona Radice, Sara Renna, Davide Giuseppe Ribaldone, Giulia Rizzuto |
| 28 |
[GO] |
2022―Aug―13 |
Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19 |
Raffaele Pellegrino, Gianluca Pellino, Francesco Selvaggi, Alessandro Federico, Marco Romano, Antonietta Gerarda Gravina |
| 29 |
[GO] |
2022―Aug―04 |
Covid-19 and alcohol associated liver disease |
Sasha Deutsch-Link, Brenda Curtis, Ashwani K. Singal |
| 30 |
[GO] |
2022―Mai―04 |
OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS |
M. Guarino, I. Esposito, G. Portella, V. Cossiga, I. Loperto, L. Pignata, R. Tortora, M.R. Attanasio, M. Cennamo, M. Capasso, D. Terracciano, F.M. Cutolo, A.G. Lanza, R. Lieto, S. Di Somma, F.P. Picciotto, F. Morisco |
| 31 |
[GO] |
2022―Mai―04 |
OC.08.1 THE IMPACT OF THE COVID-19 PANDEMIC ON HOSPITALIZATIONS FOR DIVERTICULAR DISEASE |
B. Germana’, C. Barbiellini Amidei, S. Bellio, M. Saia |
| 32 |
[GO] |
2022―Mai―04 |
T.04.10 EFFECT OF WHEY PROTEINS ON MALNUTRITION AND EXTUBATING TIME OF CRITICALLY ILL COVID-19 PATIENTS |
G. Fabiano, E. Scarpellini, M. Scarcella, A. Ascani, M. Zanetti, F. Luzza, L. Abenavoli |
| 33 |
[GO] |
2022―Mai―04 |
T.05.10 SAFETY AND FEASIBILITY OF OUTPATIENT ENDOSCOPIC FULLTHICKNESS RESECTION FOR COLORECTAL LESIONS: GET A CLEAR SKY FROM THE COVID-19 STORM |
M. Gagliardi, C. Abbatiello, M. Fusco, O. Labianca, M. Sica, C. Zulli, A. Maurano |
| 34 |
[GO] |
2022―Mai―04 |
OC.02.1 SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD) |
A. Todeschini, A. Contaldo, F.S. Macaluso, F. Facciotti, F. Castiglione, O.M. Nardone, R. Spagnuolo, P. Doldo, G. Riguccio, F.S. Conforti, C. Viganò, M. Ascolani, G. Bodini, M. Milla, G. Scardino, M. Vernero, F. Desideri, M. Mannino, G. Rizzo, A. Di Leo, A. Orlando, M. Principi |
| 35 |
[GO] |
2022―Mai―04 |
PC.01.4 REDUCED IMMUNE RESPONSE INDUCED BY TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IG-IBD STUDY |
F.S. Macaluso, M. Principi, F. Facciotti, A. Contaldo, A. Todeschini, S. Saibeni, C. Bezzio, F. Castiglione, O.M. Nardone, R. Spagnuolo, P. Doldo, M.C. Fantini, S. Paba, G. Riguccio, F.S. Conforti, C. Viganò, M. Ascolani, G. Bodini, M. Milla, G. Scardina, M. Vernero, F. Desideri, M. Mannino, G. Rizzo, F.A. Caprioli, A. Orlando |
| 36 |
[GO] |
2022―Mai―04 |
T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION |
M. Romeo, M. Dallio, M. Cipullo, S. Olivieri, G. Iadanza, M. Sangineto, L. Ventriglia, F. Scognamiglio, A. Federico |
| 37 |
[GO] |
2022―Mai―04 |
OC.10.2 A SERUM METABOLOMICS ANALYSIS TO UNDERSTAND THE INTERPLAY BETWEEN BIOLOGICAL THERAPIES IN IBD PATIENTS AND SUSCEPTIBILITY TO SARS-COV-2 INFECTION |
L.F. Pisani, S. Mola, G. Crespi, F. Caprioli, M. Annunaziata, M. Manfredi, L. Pastorelli, C. Porta |
| 38 |
[GO] |
2022―Mai―04 |
OC.02.2 REDUCED EXPRESSION OF SARS-COV-2 INFECTION-RELATED GENES IN INFLAMMATORY BOWEL DISEASE PATIENTS |
L.F. Pisani, S. Mola, G. Crespi, F. Caprioli, M. Annunziata, C. Porta, L. Pastorelli |
| 39 |
[GO] |
2022―Mai―04 |
T.07.7 INCREASED NUMBER OF COLORECTAL INTERVAL CANCERS IN LYNCH SYNDROME AFTER THE SARS-COV-2 PANDEMIC. A SURVEY-BASED STUDY |
A. Mannucci, M. Puzzono, M. Russo, A. Barchi, R.A. Zuppardo, P. Biamonte, S. Bencardino, G. Leandro, R. Cannizzaro, F. Monica, R.M. Zagari, L. Pasquale, E. Goni, M. Di Leo, L. Ricciardiello, G.M. Cavestro |
| 40 |
[GO] |
2022―Mai―04 |
T.06.3 DOES SARS-COV-2 VACCINATION AFFECT THE COURSE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS ON BIOLOGICAL THERAPY? |
F. De Blasio, M. Montori, F. Martini, L. Paolucci, T. Vitalini, G. Pieroni, C. Quatraccioni, A. Benedetti |
| 41 |
[GO] |
2022―Mai―04 |
T.03.7 PRELIMINARY RESULTS ON SARS-COV-2 VACCINATION RESPONSE IN PATIENTS WITH COELIAC DISEASE AND NON-COELIAC ENTEROPATHIES: A SINGLE-CENTRE CASE-CONTROL STUDY |
D. Scalvini, A. Schiepatti, S. Maimaris, R. Muscia, V. Gregorio, E. Cosentini, E. Roda, C.A. Locatelli, F. Biagi |
| 42 |
[GO] |
2022―Mai―04 |
T.03.10 HENOCH-SCHONLEIN PURPURA FOLLOWING EXPOSURE TO SARS-COV2 MRNA VACCINE: A CASE REPORT |
F. Di Vincenzo, M. Pizzoferrato, S. Bibbò, S. Ennas, S. Porcari, G. Cammarota |
| 43 |
[GO] |
2022―Mai―04 |
OC.08.3 IMPACT OF ENVIRONMENTAL CHANGES FORCED BY PANDEMIC RESTRICTIVE MEASURES ON THE DEVELOPMENT AND COURSE OF IRRITABLE BOWEL SYNDROME |
S. Kayali, M. Furnari, S. Ziola, E. Giuliana, E. Casagrande, A. Djahandideh, E. Marabotto, G. Bodini, M. Martini, Y. Marten Canavesio, E.G. Giannini |
| 44 |
[GO] |
2022―Mai―04 |
T.07.6 PATIENTS REFERRED TO ANORECTAL MANOMETRY BEFORE AND DURING THE COVID PANDEMIC: ARE THEY DIFFERENT? |
C. Lambiase, F. Rettura, A. Pancetti, R. Morganti, G. Berti, F. Baiano Svizzero, L. Mariani, D. Stefani Donati, N. De Bortoli, M. Bellini |
| 45 |
[GO] |
2022―Apr―11 |
Have telephone reminders been a good way to reduce non-attendance rates for endoscopy during the COVID-19 pandemic? |
Nicoletta Nandi, Elisa Farina, Laura Visconti, Paolo Canté, Luca Elli, Roberto Penagini |
| 46 |
[GO] |
2022―Mrz―22 |
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis |
Deepak James, Anuraag Jena, Pardhu Neelam Bharath, Arup Choudhury, Anupam K. Singh, Shaji Sebastian, Vishal Sharma |
| 47 |
[GO] |
2022―Mrz―21 |
Metabolic dysfunction-associated fatty liver disease and liver fibrosis score in patients with COVID-19 as predictors of adverse clinical outcomes: an artificial intelligent application through machine learning |
A. Dalbeni, M. Zoncapè, M. Carlin, M. Bicego, A. Simonetti, V. Ceruti, A. Mantovani, F. Inglese, G. Zamboni, A. Sartorio, P. Minuz, S. Romano, E. Crisafulli, C. Fava, D. Sacerdoti |
| 48 |
[GO] |
2022―Mrz―21 |
Expert consensus criteria and practical recommendations for pbc care in the covid-19 era and beyond |
M. Berenguer, A.E. Kremer, G. Hirschfield, D. Jones, V. Leroy, F. Adekunle, M. Carbone |
| 49 |
[GO] |
2022―Mrz―21 |
Humoral response to 2-dose BNT162b2 mRNA vaccine for Covid-19 in liver transplant recipients |
M. Guarino, I. Esposito, G. Portella, V. Cossiga, I. Loperto, L. Pignata, R. Tortora, M.R. Attanasio, M. Cennamo, M. Capasso, D. Terracciano, F.M. Cutolo, A.G. Lanza, R. Lieto, S. Di Somma, F.P. Picciotto, F. Morisco |
| 50 |
[GO] |
2022―Mrz―21 |
Impact of deterioration of lifestyle and PNPLA3 genotype in NALFD patients during COVID-19 lockdown |
F. Cinque, A. Cespiati, R. Lombardi, P. Francione, G. Maffi, F. Alletto, G. Sigon, G. Oberti, L. Colavolpe, P. Dongiovanni, E. Fatta, G. Pisano, S. Fargion, A.L. Fracanzani |
| 51 |
[GO] |
2022―Mrz―21 |
Implementation of hcv screening in the 1969-1989 birth-cohort undergoing covid-19 vaccination: a pivotal study in Italy |
R. D'Ambrosio, G. Rizzardini, M. Puoti, S. Fagiuoli, M.P. Anolli, C. Gabiati, F. D'Amico, L. Pasulo, U. Restelli, M. Colombo, P. Lampertico |
| 52 |
[GO] |
2022―Mrz―21 |
SARS-CoV-2 infection in liver transplantation is associated with favorable outcomes: an Italian transplant registry study |
M. Rendina, M. Barone, S. Trapani, L. Masiero, P. Trerotoli, F. Puoti, L.G. Lupo, S. Agnes, A. Grieco, E. Andorno, S. Marenco, U. Baccarani, P. Toniutto, A. Carraro, A. Colecchia, M. Cescon, M.C. Morelli, U. Cillo, P. Burra, P. Angeli, M. Colledan, S. Fagiuoli, L. De Carlis, L. Belli, P. De Simone, P. Carrai, F. Di Benedetto, N. De Maria, G.M. Ettorre, V. Giannelli, S. Gruttadauria, R. Volpes, V. Mazzaferro, S. Bhoori, R. Romagnoli, S. Martini, G. Rossi, F. Donato, M. Rossi, S. Ginanni Corradini, M. Spada, G. Maggiore, G. Tisone, I. Lenci, G. Vennarecci, G.G. Di Costanzo, M. Vivarelli, G. Svegliati Baroni, F. o Zamboni, L. Mameli, S. Tafuri, S. Simone, L. Gesualdo, M. Cardillo, A. Di Leo |
| 53 |
[GO] |
2022―Mrz―21 |
Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
M. Iavarone, G. Tosetti, F. Facchetti, M. Topa, A. Lombardi, R. D'Ambrosio, E. Degasperi, A. Loglio, C. Oggioni, A. Bandera, A. Gori, F. Ceriotti, L. Scudeller, A. Bertoletti, P. Lampertico |
| 54 |
[GO] |
2022―Mrz―21 |
Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination |
C. Rigamonti, B. Coco, M. Brunetto, S. Labanca, E.G. Giannini, B. Magro, S. Fagiuoli, G. Svegliati Baroni, C. Sgamato, L. Miele, A. Grieco, L. Giuli, G.F. Manfredi, M. Pirisi |
| 55 |
[GO] |
2022―Mrz―21 |
Longevity of seropositivity after anti SARS-CoV-2 vaccination in patients awaiting liver transplant |
A. Calleri, M. Saracco, R. Romagnoli, S. Martini |
| 56 |
[GO] |
2022―Mrz―21 |
Screening for HCV infection combined with SARS-CoV-2 vaccination in the Campania region |
P. Torre, M. Annunziata, R. Sciorio, R. Coppola, L. Staiano, C. Coppola, M. Masarone, M. Persico |
| 57 |
[GO] |
2022―Mrz―09 |
Impact of COVID-19 pandemic on pediatric endoscopy: a multicenter study on behalf of the SIGENP Endoscopy Working Group |
Sara Renzo, Luca Scarallo, Luca Maria Antoniello, Matteo Bramuzzo, Andrea Chiaro, Fabio Cisarò, Anna Chiara Iolanda Contini, Gian Luigi De Angelis, Paola De Angelis, Giovanni Di Nardo, Enrico Felici, Silvia Iuliano, Francesco Macchini, Cecilia Mantegazza, Stefano Martelossi, Salvatore Oliva, Flavia Parrinello, Francesca Rea, Antonio Pizzol, Claudio Romano, Giusy Russo, Naire Sansotta, Paolo Lionetti, Emanuele Dabizzi, Marco Deganello Saccomani, Michele Di Toma, Simona Gatti, Maria Teresa Illiceto, Sara Isoldi, Marta Maino, Maristella Pellegrino, Caterina Strisciuglio |
| 58 |
[GO] |
2022―Feb―14 |
Gastrointestinal sequelae among COVID-19 patients after discharge and their predictors |
Jayanta Samanta, Seerat Singh, Sanjay Kumar, Megha Sharma, Rakesh Kochhar |
| 59 |
[GO] |
2022―Jan―31 |
Role of the multidisciplinary team in pandemics: A new opportunity to achieve greater immunization in patients with inflammatory bowel disease |
Paulina Núñez, Rodrigo Quera, Lilian Flores, Raúl Araya, Andrea Córdova, Ismael Correa |
| 60 |
[GO] |
2022―Jan―12 |
LIVER HISTOPATHOLOGICAL CHANGES AND COVID-19: WHAT DOES LITERATURE HAVE TO TELL US? |
Jorge Lucas de Sousa Moreira, Sarah Maria Bacurau Barbosa, Jacyanne Gino Vieira, Nicolly Castelo Branco Chaves, Jucier Gonçalves Júnior |
| 61 |
[GO] |
2021―Dez―27 |
Hepatocellular liver injury in hospitalized patients affected by COVID-19: presence of different risk factors at different time points |
M. Leo, A. Galante, A. Pagnamenta, L. Ruinelli, F.R. Ponziani, A. Gasbarrini, A. De Gottardi |
| 62 |
[GO] |
2021―Okt―04 |
Effect of lockdown on digestive system cancer care among older patients during the first wave of COVID-19: the CADIGCOVAGE multicentre cohort study |
Thomas Aparicio, Richard Layese, François Hemery, Christophe Tournigand, Elena Paillaud, Nicola De Angelis, Laurent Quero, Nathalie Ganne, Fredéric Prat, Atanas Pachev, Gilles Galula, Marc-Antoine Benderra, Florence Canouï-Poitrine |
| 63 |
[GO] |
2021―Sep―20 |
OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY |
F. Ferretti, R. Cannatelli, M.C. Monico, A.M. Carvalhas Gabrielli, S. Carmagnola, G. Maconi, S. Ardizzone |
| 64 |
[GO] |
2021―Sep―20 |
AF.93 COVID-19 IN LIVER TRANSPLANT RECIPIENTS: AN ITALIAN CASE-CONTROL DOUBLE-CENTER STUDY |
M. Guarino, V. Cossiga, I. Loperto, I. Esposito, R. Ortolani, A. Fiorentino, G. Pontillo, L. De Coppi, L. Pignata, M. Capasso, V. Cozza, G.G. Di Costanzo, F.P. Picciotto, F. Morisco |
| 65 |
[GO] |
2021―Sep―20 |
OC.04.1 HIGH LEVELS OF TRANSAMINASES AT ADMISSION PREDICT A SEVERE DISEASE COURSE IN COVID-19 HOSPITALIZED PATIENTS |
F. Pelizzaro, M.P. Kitenge, F. Maran, E. Cocconcelli, E. Balestro, P. Spagnolo, A. Cattelan, F. Farinati |
| 66 |
[GO] |
2021―Sep―20 |
AF.157 EUS-GUIDED GALLBLADDER DRAINAGE: A VALUABLE OPTION IN THE COVID-19 ERA |
E. Armellini, M.O. Brizi, F. Macchini, M. Marini, F. Rubertà, L. Vescovi, A. Piazzini-Albani, F. Pace |
| 67 |
[GO] |
2021―Sep―20 |
OC.02.9 IMPACT OF COVID-19 OUTBREAK ON GASTRO-INTESTINAL CANCER BURDEN |
S.M. Milluzzo, E.V. Pesatori, C. Hassan, N. Olivari, L. Minelli Grazioli, P. Cesaro, M. Valerio, C. Spada |
| 68 |
[GO] |
2021―Sep―20 |
OC.01.3 NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING HOSPITALIZATION DURING THE FIRST PHASE OF THE COVID-19 PANDEMIC IN VENETO REGION |
B. Germana”, S. Bellio, C. Barbiellini Amidei, G. Capodaglio, F. Avossa, E. Narne, G. Pitter, U. Fedeli, E. Rosa-Rizzotto, M. Saia |
| 69 |
[GO] |
2021―Sep―20 |
PC.01.11 IMPACT OF COVID-19 PANDEMIC ON COLONOSCOPY AND SURGICAL INTERVENTIONS FOR COLORECTAL CANCER IN VENETO REGION |
B. Germana’, S. Bellio, C. Barbiellini Amidei, G. Capodaglio, F. Avossa, E. Narne, G. Pitter, U. Fedeli, M. Zorzi, E. Rosa-Rizzotto, M. Pantalena, M. Saia |
| 70 |
[GO] |
2021―Sep―20 |
OC.04.8 IMPACT OF COVID-19 PANDEMIC ON REFERRAL OF PATIENTS WITH LIVER DISEASE TO A LIVER TRANSPLANT CENTER |
G. Germani, M. Pellone, A. Ferrarese, A. Zanetto, S. Shalaby, G. Carretta, D. Donato, U. Cillo, P. Feltracco, P. Persona, E. Serra, M. Gambato, M. Senzolo, F.P. Russo, P. Burra |
| 71 |
[GO] |
2021―Sep―20 |
OC.06.8 THE EMERGING ROLE OF TELEMEDICINE IN GASTROENTEROLOGY DURING THE COVID-19 PANDEMIC: A STUDY ON ITS FEASIBILITY AND PATIENTS’ TRUST |
A. Costantino, L. Elli, L. Roncoroni, D. Noviello, F.S. Conforti, N. Nandi, S. Mazza, M. Vecchi, F. Caprioli |
| 72 |
[GO] |
2021―Sep―20 |
AF.78 THE PARADOX OF COVID-19 PANDEMIC: EFFECT OF LOCKDOWN ON THE IMPROVEMENT OF IRRITABLE BOWEL SYNDROME SEVERITY |
M. Andreozzi, B. Polese, N. Mancino, V. Vaino, G. Di Giorgio, S. Rurgo, G. Sarnelli, M. Pesce |
| 73 |
[GO] |
2021―Sep―20 |
AF.39 INFLAMMATORY BOWEL DISEASE VIDEO-CONSULTING: A SATISFACTION SURVEY DURING THE SECOND WAVE OF COVID-19 PANDEMICS |
A. Todeschini, A. Contaldo, I. Lacavalla, E. Ierardi, A. Di Leo, M. Principi |
| 74 |
[GO] |
2021―Sep―20 |
AF.53 THE LEGACY OF COVID-19 PANDEMICS: REMOTE MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE AS AN EFFECTIVE MANAGEMENT STRATEGY |
A. Busacca, E. Sinagra, L. Guida, L. Carrozza, M. Maida, S. Battaglia, C. Celsa, C. Cammà, M. Cappello |
| 75 |
[GO] |
2021―Sep―20 |
AF.49 DETERMINANTS OF COVID-19 VACCINE HESITANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): RESULTS OF A NATIONAL SURVEY OF THE ITALIAN IBD PATIENTS’ ASSOCIATION (AMICI ONLUS) |
A. Costantino, D. Noviello, F.S. Conforti, M. Aloi, A. Armuzzi, F. Bossa, F. Ficari, S. Leone, F. Manguso, G. Mocci, A. Orlando, L. Pironi, S. Radice, F. Rizzello, A. Tongiorgi, C. Costantino, M. Vecchi, F. Caprioli |
| 76 |
[GO] |
2021―Sep―20 |
AF.27 COVID-19 VACCINE: A SURVEY ON HESITANCY IN PATIENTS WITH CELIAC DISEASE |
A. Costantino, M. Topa, L. Roncoroni, V. Lombardo, D. Stocco, A. Gramegna, C. Costantino, V. Maurizio, L. Elli |
| 77 |
[GO] |
2021―Sep―20 |
PC.01.3 SEVERE ACTIVITY OF INFLAMMATORY BOWEL DISEASE IS A RISK FACTOR FOR SEVERE COVID-19: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD) |
F.S. Macaluso, A. Giuliano, W. Fries, A. Viola, A. Abbruzzese, M. Cappello, E. Giuffrida, L. Carrozza, A.C. Privitera, A. Magnano, C. Ferracane, G. Scalisi, M.G. Minissale, E. Giangreco, S. Garufi, C. Bertolami, U. Cucinotta, F. Graziano, S. Renna, G. Rizzuto, M. Maida, A. Orlando |
| 78 |
[GO] |
2021―Sep―20 |
AF.86 THE ANALYSIS OF ALCOHOL CONSUMPTION DURING THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ITALIAN LOCKDOWN |
M. Romeo, M. Dallio, A.G. Gravina, C. Mazzarella, A. Spina, C. Loguercio, A. Federico |
| 79 |
[GO] |
2021―Sep―20 |
AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY |
C.B. Conti, E. Mainardi, S. Soro, S. Testa, A. De Silvestri, A. Drago, F. Cereatti, R. Grassia |
| 80 |
[GO] |
2021―Sep―20 |
AF.94 IMPACT OF SARS-COV-2 INFECTION IN WAITING LIST FOR LIVER TRANSPLANTATION |
A. Sessa, A. Mazzola, B. Granger, L. Walkselman, M. Atif, V. Pourcher, M. Mallet, D. Thabut, O. Scatton, F. Conti |
| 81 |
[GO] |
2021―Sep―20 |
OC.07.2 FUNCTIONAL GASTROINTESTINAL AND SOMATOFORM SYMPTOMS FIVE MONTHS AFTER SARS-COV-2 INFECTION: A CONTROLLED COHORT STUDY |
D. Noviello, A. Costantino, A. Muscatello, A. Bandera, D. Consonni, M. Vecchi, G. Basilisco |
| 82 |
[GO] |
2021―Sep―20 |
AF.140 ASSESSMENT OF THE EUS PROCEDURES IN A NORTH ITALIAN ENDOSCOPY UNIT DURING THE 2020 COVID PANDEMIC |
T. Togliani, I. Breoni, V. Davì, N. Mantovani, E. Vitetta, S. Pilati |
| 83 |
[GO] |
2021―Aug―09 |
POST COVID-19 Cholangiopathy - A Deep Dive |
Lakshmi Deepak Bethineedi, Tarun Kumar Suvvari |
| 84 |
[GO] |
2021―Jul―24 |
Correct use of telemedicine in gastroenterology, hepatology, and endoscopy during and after the COVID-19 pandemic: Recommendations from the Italian association of hospital gastroenterologists and endoscopists (AIGO) |
Andrea Costantino, Francesco Bortoluzzi, Mauro Giuffrè, Roberto Vassallo, Luigi Maria Montalbano, Fabio Monica, Daniele Canova, Davide Checchin, Paolo Fedeli, Riccardo Marmo, Luca Elli |
| 85 |
[GO] |
2021―Jun―28 |
Reply to: “Characteristics and In-Hospital Outcomes of COVID-19 Patients with Acute or Subacute Liver Failure” |
walid ibrahim yousif |
| 86 |
[GO] |
2021―Jun―26 |
Safety of gastrointestinal endoscopy during the COVID-19 pandemic: A new quality indicator? |
Dr. Francesca Gauci, Dr. Ayrton Borg Axisa, Dr. Andrea Vella Baldacchino, Dr. Pierre Ellul |
| 87 |
[GO] |
2021―Jun―07 |
No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience |
Fabiola De Biasio, Annalisa Aratari, Stefano Festa, Roberto Lorenzetti, Claudio Papi |
| 88 |
[GO] |
2021―Mai―31 |
Characteristics and In-Hospital Outcomes of COVID-19 Patients with Acute or Subacute Liver Failure |
Yiyan Zhang, Xiaozhong Guo, Zhuang Ma, Bing Wang, Hui Lu, Xingshun Qi |
| 89 |
[GO] |
2021―Mai―26 |
Acute splanchnic vein thrombosis in patients with COVID-19: a systematic review |
Giacomo Buso, Chiara Becchetti, Annalisa Berzigotti |
| 90 |
[GO] |
2021―Apr―30 |
Italian association for the study of the liver position statement on SARS-CoV2 vaccination |
Francesco Paolo Russo, Salvatore Piano, Raffaele Bruno, Patrizia Burra, Massimo Puoti, Mario Masarone, Sara Montagnese, Francesca Romana Ponziani, Salvatore Petta, Alessio Aghemo |
| 91 |
[GO] |
2021―Apr―27 |
Endoscopy during the COVID-19 pandemic: is it time to down-grade personal protective equipment for vaccinated personnel? |
Luca Elli, Alessandro Rimondi, Eugenio Tontini, Andrea Gori, Maurizio Vecchi, Roberto Penagini |
| 92 |
[GO] |
2021―Apr―19 |
Reply to: “Liver fibrosis and adverse outcomes in COVID-19” |
Astrid Ruiz-Margáin, Alejandro Campos-Murguía, José Alberto González-Regueiro, Berenice Monserrat Román-Calleja, Deyanira Kúsulas Delint, Ricardo Ulises Macías-Rodríguez |
| 93 |
[GO] |
2021―Apr―02 |
Liver fibrosis and adverse outcomes in COVID-19 |
Jianmin Huang |
| 94 |
[GO] |
2021―Mrz―27 |
Management of patients with Inflammatory Bowel Disease and outcomes during the first wave of the Covid-19 pandemic |
Anna Viola, Federica Giambò, Michele Francesco Chiappetta, Giuseppe Costantino, Socrate Pallio, Walter Fries |
| 95 |
[GO] |
2021―Mrz―20 |
Factors associated with risk of COVID-19 contagion for endoscopy healthcare workers: a survey from the Italian Society of Digestive Endoscopy. |
Alberto Mariani, Gabriele Capurso, Giovanni Marasco, Helga Bertani, Stefano Francesco Crinò, Andrea Magarotto, Andrea Tringali, Luigi Pasquale, Paolo Giorgio Arcidiacono, Rocco Maurizio Zagari |
| 96 |
[GO] |
2021―Mrz―09 |
Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: a nationwide survey |
Elisabetta BUSCARINI, Antonio BENEDETTI, Fabio MONICA, Luigi PASQUALE, Francesco BUTTITTA, Michela CAMELETTI, Clarissa FERRARI, Luigi RICCIARDIELLO, Sara MASSIRONI, Maria Antonia BIANCO, Bastianello GERMANÀ, Stefano RODINÒ, Andrea ANDERLONI, Alessandro MUSSETTO, Bruno NIPOTE, Salvatore RUSSO, Raffaele MANTA, Adriano LAURI, Vincenzo OCCHIPINTI, Marco DI MARCO, Maurizio GIOVANNONE, Cecilia BINDA, Monica SBRANCIA, Maria Carla DI PAOLO, Gian Luigi DE’-ANGELIS, Giancarla FIORI, Marco DAL-FANTE, Giuseppe DE CARO, Paolo USAI-SATTA, Monica CESARINI, Enrico PIRAS, Elisa STASI, Giovanni SERIO, Luigi Maria MONTALBANO, Vincenzo Giorgio MIRANTE, Osvaldo BURATTINI, Simona ATTARDO, Stefano BARGIGGIA, Manuele DINCA, Guido MISSALE, Costanza ALVISI, Francesco BROGLIA, Luca FERRARIS, Maria Cristina CONTI-BELLOCCHI, Carmelo LUIGIANO, Socrate PALLIO, Matteo BRUNACCI, Carlo MANFRINI, Rosamaria BOZZI, Davide CHECCHIN, Thomas TOGLIANI, Antonietta D'ERRICO, Franco BAZZOLI, Orazio LA-BIANCA, Debora BERRETTI, Domenico ALVARO |
| 97 |
[GO] |
2021―Feb―26 |
Could SARS-CoV-2 be associated with emphysematous gastritis? |
Sonsoles Garrosa-Muñoz, Jaime López-Sánchez, Luis Miguel González-Fernández, Luis Muñoz-Bellvís |
| 98 |
[GO] |
2021―Feb―23 |
The Fibrosis-4 index is associated with Intensive Care Unit (ICU) admission in middle-aged patients with COVID-19 |
E. Biliotti, P. Piselli, U. Visco Comandini, R. Lionetti, C. Taibi, L. Vincenzi, S. Al Moghazi, A. Antinori, E. Caraffa, C. Cimaglia, L. Marchioni, A. Mariano, I. Mastrorosa, S. Mosti, A. Navarra, E. Nicastri, F. Palmieri, E. Girardi, G. D'Offizi, ReCOVeRI Study Group |
| 99 |
[GO] |
2021―Feb―23 |
COVID-19 and Solid Organ Transplantation (SOT) in Italy: A web-survey |
F. Galiandro, S. Agnes, F. Giovinazzo, A. Vitale, R. Romagnoli, C. Amarelli, U. Maggiore, P. Burra, U. Boggi, A.W. Avolio |
| 100 |
[GO] |
2021―Feb―23 |
High levels of transaminases at admission predict a severe disease course in COVID-19 hospitalized patients |
F. Pelizzaro, M.P. Kitenge, F. Maran, E. Cocconcelli, E. Balestro, P. Spagnolo, A. Cattelan, F. Farinati |
| 101 |
[GO] |
2021―Feb―23 |
No impact of the 2020 COVID-19 lockdown on hospitalization rates for alcoholic liver disease in a large tertiary hospital in Milan |
C. Masetti, F. Colapietro, N. Pugliese, F. De Fazio, A. Voza, I Bianchi, R. Ceriani, A. Lleo, A. Aghemo |
| 102 |
[GO] |
2021―Feb―23 |
Liver Transplantation during the COVID-19 pandemic: A quantitative model balancing individual patient benefit against population healthcare needs |
U. Cillo, A. Vitale, M.L. Volk, A.C. Frigo, P. Feltracco, A. Cattelan, G. Brancaccio, G. Feltrin, P. Angeli, P. Burra, S. Lonardi, S. Trapani, M. Cardillo |
| 103 |
[GO] |
2021―Feb―23 |
Hepatocellular liver injury in hospitalized patients affected by COVID-19: Different factors at different time points |
M. Leo, A. Galante, A. Pagnamenta, F.R. Ponziani, A. Gasbarrini, A. De Gottardi |
| 104 |
[GO] |
2021―Feb―23 |
Liver transplant recipients with Covid-19: results from an Italian multicenter cohort |
C. Mazzarelli, R. Viganò, G. Perricone, M. Merli, L. Pasulo, F. Invernizzi, S. Bhoori, M.C. Morelli, D. Patrono, S. Di Sandro, P. Cortesi, D. Angrisani, S. De Nicola, M. Vangeli, L.S. Belli |
| 105 |
[GO] |
2021―Feb―23 |
Liver transplant candidates and SARS-CoV-2 infection: Results from an Italian multicenter cohort |
G. Perricone, R. Vigano, C. Mazzarelli, G. Travi, L. Pasulo, F. Invernizzi, M.C. Morelli, D. Patrono, S. Di Sandro, P. De Simone, R. Facchetti, D. Angrisani, S. De Nicola, A. Airoldi, M. Vangeli, e L.S. Belli |
| 106 |
[GO] |
2021―Feb―23 |
Metabolic alterations and hepatic fibrosis impact on severity of SARS-COV2 infection |
R. Lombardi, A. Cespiati, V. La Mura, F. Iuculano, G. Sigon, G. Pallini, M. Proietti, I. Motta, B. Montinaro, E. Fiorelli, M. Cesari, F. Peyvandi, N. Montano, M. Baldini, A.L. Fracanzani |
| 107 |
[GO] |
2021―Feb―23 |
Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: the “Casola di Napoli” cohort study |
C. Coppola, M. Masarone, M. Bartoli, L. Staiano, P. Torre, M. Conforti, D. Amoruso, I. Gardini, M. Persico |
| 108 |
[GO] |
2021―Feb―21 |
Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients |
Fabio Del Zompo, Flavio De Maio, Francesco Santopaolo, Rosalba Ricci, Maurizio Pompili, Francesca Romana Ponziani |
| 109 |
[GO] |
2021―Feb―03 |
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19 |
Alejandro Campos-Murguía, Berenice Monserrat Román-Calleja, Israel Vicente Toledo-Coronado, José Alberto González-Regueiro, Alberto Adrián Solís-Ortega, Deyanira Kúsulas-Delint, Mariana Cruz-Contreras, Nabila Cruz-Yedra, Francisco Javier Cubero, Yulia Alexandrowna Nevzorova, Carlos Fernando Martínez-Cabrera, Paulina Moreno-Guillén, Oscar Arturo Lozano-Cruz, Mónica Chapa-Ibargüengoitia, Alfonso Gulías-Herrero, Carlos Alberto Aguilar-Salinas, Astrid Ruiz-Margáin, Ricardo Ulises Macías-Rodríguez |
| 110 |
[GO] |
2021―Jan―15 |
Successful coping with SARS-CoV-2 infection of adult celiac patients assessed by telemedicine |
Gloria Galli, Gianluca Esposito, Emanuele Dilaghi, Bruno Annibale, Edith Lahner, Laura Conti |
| 111 |
[GO] |
2021―Jan―10 |
Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs |
Fabrizio Bossa, Sonia Carparelli, Anna Latiano, Orazio Palmieri, Francesca Tavano, Anna Panza, Maria Pastore, Antonio Marseglia, Mario D'Altilia, Tiziana Latiano, Giuseppe Corritore, Giuseppina Martino, Marianna Nardella, Maria Guerra, Fulvia Terracciano, Michele Sacco, Francesco Perri, Angelo Andriulli |
| 112 |
[GO] |
2020―Dez―26 |
COVID-19 in IBD: the experience of a single tertiary IBD center |
Prof Fernando Rizzello, Carlo Calabrese, Marco Salice, Lucia Calandrini, Hana Privitera, Laura Melotti, Giulia Peruzzi, Nikolas Dussias, Andrea Belluzzi, Eleonora Scaioli, Anastasio Decorato, Antonio Siniscalchi, Eleonora Filippone, Prof Silvio Laureti, Matteo Rottoli, Prof Gilberto Poggioli, Prof. Paolo Gionchetti |
| 113 |
[GO] |
2020―Dez―26 |
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group |
Serena Arrigo, Patrizia Alvisi, Claudia Banzato, Matteo Bramuzzo, Rosaria Celano, Fortunata Civitelli, Giulia D'Arcangelo, Anna Di Lillo, Valeria Dipasquale, Enrico Felici, Maurizio Fuoti, Simona Gatti, Daniela Knafelz, Paolo Lionetti, Federica Mario, Antonio Marseglia, Stefano Martelossi, Chiara Moretti, Lorenzo Norsa, Roberto Panceri, Sara Renzo, Claudio Romano, Erminia Romeo, Caterina Strisciuglio, Massimo Martinelli |
| 114 |
[GO] |
2020―Dez―18 |
Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR) |
David Tougeron, Pierre Michel, Astrid Lièvre, Michel Ducreux, Sébastien Gaujoux, Boris Guiu, Florence Huguet, Thierry Lecomte, Côme Lepage, Christophe Louvet, Léon Maggiori, Pascale Mariani, Thomas Aparicio, Olivier Bouché |
| 115 |
[GO] |
2020―Dez―13 |
Management of gastrointestinal tuberculosis during COVID pandemic: Lessons for posterity |
Jayendra Shukla, Anuraag Jena, Harjeet Singh, Harshal S. Mandavdhare, Usha Dutta, Vishal Sharma |
| 116 |
[GO] |
2020―Nov―11 |
Does MAFLD really increase the severity of COVID-19? |
Jonny Karunia Fajar, Bogi Pratomo Wibowo, Gheavita Chandra Dewi, Adi Putra Rahmadi, Meike Tiya Kusuma |
| 117 |
[GO] |
2020―Nov―05 |
COVID-19 and Pneumatosis Intestinalis: An Early Sign of Intestinal Ischemia |
Wesam Hassan, Haidi Karam-Allah Ramadan |
| 118 |
[GO] |
2020―Nov―05 |
Trust in telemedicine from IBD outpatients during the COVID-19 pandemic |
A. Costantino, D. Noviello, S. Mazza, R. Berté, F. Caprioli, M. Vecchi |
| 119 |
[GO] |
2020―Nov―05 |
Reply to "Does MAFLD really increase the severity of COVID-19?" |
Lu Pan, Pan Huang, Xia Xie, Jiachen Xu, Dawei Guo, Yuan Jiang |
| 120 |
[GO] |
2020―Okt―23 |
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: a position paper on behalf of the SIGENP IBD Working Group |
Serena Arrigo, Patrizia Alvisi, Claudia Banzato, Matteo Bramuzzo, Fortunata Civitelli, Antonio Corsello, Giulia D'Arcangelo, Anna Di Lillo, Valeria Dipasquale, Enrico Felici, Maurizio Fuoti, Simona Gatti, Zeno Giusti, Daniela Knafeltz, Paolo Lionetti, Federica Mario, Antonio Marseglia, Stefano Martelossi, Chiara Moretti, Lorenzo Norsa, Federica Nuti, Roberto Panceri, Stefania Rampado, Sara Renzo, Claudio Romano, Erminia Romeo, Caterina Strisciuglio, Massimo Martinelli |
| 121 |
[GO] |
2020―Okt―19 |
Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic |
Anuraag Jena, Praveen Kumar-M, Anupam Kumar Singh, Vishal Sharma |
| 122 |
[GO] |
2020―Okt―14 |
Low Risk of Transmission of SARS-CoV2 and Effective Endotherapy for Gastrointestinal Bleeding Despite Challenges Supports Resuming Optimum Endoscopic Services |
Ashish Agarwal, Sudipta Dhar Chowdhury, Sanjeev Sachdeva, Vivek Saraswat, Rakesh Kochhar, Anoop Saraya |
| 123 |
[GO] |
2020―Okt―08 |
Endoscopic ultrasound-guided gastro-enteric anastomosis in the COVID era: May the pandemic emphasize the benefit? |
Alessandro Fugazza, Marco Spadaccini, Stefania Bramanti, Carlo Castoro, Alessandro Repici, Andrea Anderloni |
| 124 |
[GO] |
2020―Okt―06 |
Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection |
Timotius Ivan Hariyanto, Ignatius Bima Prasetya, Andree Kurniawan |
| 125 |
[GO] |
2020―Okt―03 |
How an endoscopy unit changed and was partially converted into an ICU during COVID-19 emergency in a tertiary referral hospital of Northern Italy |
Vincenzo Giorgio Mirante, Giorgio Mazzi, Gerolamo Bevivino, Francesca Parmeggiani, Giorgio Iori, Romano Sassatelli |
| 126 |
[GO] |
2020―Sep―29 |
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study |
Gianluca Ianiro, Stefano Bibbò, Luca Masucci, Gianluca Quaranta, Serena Porcari, Carlo Romano Settanni, Loris Riccardo Lopetuso, Massimo Fantoni, Maurizio Sanguinetti, Antonio Gasbarrini, Giovanni Cammarota |
| 127 |
[GO] |
2020―Sep―29 |
Splanchnic vein thrombosis in COVID-19: A Review of Literature |
Balraj Singh, Parminder Kaur, Michael Maroules |
| 128 |
[GO] |
2020―Sep―22 |
COVID-19 and intestinal inflammation: role of fecal calprotectin |
Veronica Ojetti, Angela Saviano, Marcello Covino, Nicola Acampora, Eliana Troiani, Francesco Franceschi |
| 129 |
[GO] |
2020―Sep―19 |
Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial |
Anuraag Jena, Anupam Kumar Singh, Praveen Kumar-M, Vishal Sharma, Shaji Sebastian |
| 130 |
[GO] |
2020―Sep―17 |
Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis |
Lu Pan, Pan Huang, Xia Xie, Jiachen Xu, Dawei Guo, Yuan Jiang |
| 131 |
[GO] |
2020―Sep―16 |
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis |
Vincenzo Cardinale, Gabriele Capurso, Gianluca Ianiro, Antonio Gasbarrini, Paolo Giorgio Arcidiacono, Domenico Alvaro |
| 132 |
[GO] |
2020―Sep―06 |
COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW OF CLINICAL DATA |
Fabio Salvatore Macaluso, Ambrogio Orlando |
| 133 |
[GO] |
2020―Sep―04 |
Hospitalized coronavirus disease-2019 (COVID-19) patients with gastrointestinal symptoms have improved survival to discharge |
Benjamin D. Renelus, Neil Khoury, Karthik Chandrasekaran, Ezana Bekele, William M. Briggs, Daniel S. Jamorabo |
| 134 |
[GO] |
2020―Aug―31 |
URGENT SURGERY FOR INFLAMMATORY BOWEL DISEASES DURING THE COVID-19 OUTBREAK IN A HIGH INCIDENCE AREA - EXPERIENCE FROM A HIGH-VOLUME CENTRE |
Fiorenzo Botti, Stefano Mazza, Stefano Costa, Elisa Farina, Ludovica Baldari, Matteo Prati |
| 135 |
[GO] |
2020―Aug―29 |
Covid-19 post-lockdown: a transparent box, used as protective equipment in gastroscopy. A test of feasibility and efficacy |
Ofir Har-Noy, Lev Lichtenstein, Evgeny Landa, Zvika Marcus, Gil Ovadia, Jorge-Shmuel Delgado |
| 136 |
[GO] |
2020―Aug―25 |
Does interval time between liver transplant and COVID-19 infection make the difference? |
Vincenzo Buscemi, Riccardo De Carlis, Andrea Lauterio, Marco Merli, Massimo Puoti, Luciano De Carlis |
| 137 |
[GO] |
2020―Aug―10 |
Systemic inflammation as fuel for acute liver injury in COVID-19 |
Maria Effenberger, Christoph Grander, Felix Grabherr, Andrea Griesmacher, Thomas Ploner, Frank Hartig, Rosa Bellmann-Weiler, Michael Joannidis, Heinz Zoller, Günter Weiss, Timon Erik Adolph, Herbert Tilg |
| 138 |
[GO] |
2020―Jul―27 |
Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre |
Fabiana Zingone, Andrea Buda, Edoardo Savarino |
| 139 |
[GO] |
2020―Jul―27 |
Safe administration of corticosteroids in severe ulcerative colitis and active SARS-CoV2 infection |
Pierre Mayer, Antonio Saviano, Loïc Kassegne, Thomas F. Baumert, Jean-Marie Reimund, François Habersetzer |
| 140 |
[GO] |
2020―Jul―23 |
Digestive and Liver Diseases and the COVID-19 Pandemic |
Roberto de Franchis |
| 141 |
[GO] |
2020―Jul―21 |
How endoscopy centers prepare to reopen after the acute COVID-19 pandemic interruption of activity |
V Castagna, E Armellini, F Pace, C Alvisi, S Agazzi, A Amato, L Dioscoridi, E Filippi, C Gemme, V Imbesi, G Manes, M Mutignani, S Orlando, R Penagini, F Radaelli, R Reati, M Schettino, D Stradella, G Venezia, C Verna |
| 142 |
[GO] |
2020―Jul―21 |
Will “Video kill the Radiostar” or is zooming just a pandemic transient Hype? Some cautionary notes |
Guilherme Macedo |
| 143 |
[GO] |
2020―Jul―19 |
NONINVASIVE MONITORING OF INFLAMMATORY BOWEL DISEASE IN THE POST COVID-19 ERA |
Olga Maria Nardone, Antonio Rispo, Fabiana Castiglione |
| 144 |
[GO] |
2020―Jul―15 |
Trends in cirrhosis hospitalizations during the COVID-19 pandemic |
R. Gaspar, R. Liberal, Catarina Castelo Branco, G. Macedo |
| 145 |
[GO] |
2020―Jul―14 |
Prevalence of functional gastrointestinal disorders in children with celiac disease during the COVID-19 lockdown |
Francesca Fiori Nastro, Carlo Tolone, Maria Rosaria Serra, Daniela Pacella, Angelo Campanozzi, Caterina Strisciuglio |
| 146 |
[GO] |
2020―Jul―12 |
SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy? |
Bardasi Giulia, Alvisi Patrizia |
| 147 |
[GO] |
2020―Jul―10 |
Assessing the Impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian Association for the Study of the Liver |
Alessio Aghemo, Mario Masarone, Sara Montagnese, Salvatore Petta, Francesca Romana Ponziani, Francesco Paolo Russo |
| 148 |
[GO] |
2020―Jul―10 |
Reorganization of the Functional Gastrointestinal Disorders Unit during the SARS-CoV-2 Outbreak - Practical Recommendations |
Matteo Ghisa, Brigida Barberio, Greta Lorenzon, Fabiana Zingone, Edoardo Savarino |
| 149 |
[GO] |
2020―Jul―07 |
Children and Fecal SARS-CoV-2 shedding: Just the Tip of the Iceberg of Italian COVID-19 outbreak? |
Salvatore Oliva, Salvatore Cucchiara, Franco Locatelli |
| 150 |
[GO] |
2020―Jul―06 |
Unchanged surgical management of patients with Cholangiocarcinoma during the COVID-19 pandemic |
Enrico Gringeri, Martina Gambato, Alessandro Furlanetto, Mattia Ballo, Eleonora Nieddu, Umberto Cillo |
| 151 |
[GO] |
2020―Jul―03 |
Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms |
Mathieu Uzzan, Damien Soudan, Katell Peoch, Emmanuel Weiss, Olivier Corcos, Xavier Treton |
| 152 |
[GO] |
2020―Jun―29 |
Performing endoscopy in a reorganised gastroenterology department during pandemic lockdown |
Renato Medas, Patrícia Andrade, Pedro Moutinho-Ribeiro, Guilherme Macedo |
| 153 |
[GO] |
2020―Jun―23 |
Who comes first: rescheduling endoscopic activity after the acute phase of the Covid 19 pandemic |
Giulia Tripodi, Emanuele Dilaghi, Silvia Fanella, Vito Domenico Corleto, Emilio Di Giulio |
| 154 |
[GO] |
2020―Jun―19 |
Planning Phase Two for Endoscopic Units in Northern Italy after the COVID-19 lockdown: an exit strategy with a lot of critical issues and a few opportunities |
Gianpiero Manes, Alessandro Repici, Franco Radaelli, Cristina Bezzio, Matteo Colombo, Simone Saibeni |
| 155 |
[GO] |
2020―Jun―18 |
The management of Inflammatory Bowel Diseases in the era of COVID-19 pandemic: when “non-urgent” does not mean “deferrable” |
Daniela Pugliese, Claudio Papi, Giuseppe Privitera, Annalisa Aratari, Stefano Festa, Alessandro Armuzzi |
| 156 |
[GO] |
2020―Jun―16 |
Delivery of care remotely through telemedicine in celiac disease: Thinking beyond COVID-19 |
M. Ines Pinto-Sanchez, Benjamin Lebwohl |
| 157 |
[GO] |
2020―Jun―16 |
Five recommendations for loco-regional treatments of hepatocellular carcinoma during the COVID-19 pandemic |
Roberto Santambrogio, Elisa Galfrascoli, Marco Antonio Zappa |
| 158 |
[GO] |
2020―Jun―15 |
Reorganization of the endoscopic activity of Cancer Institutes during phase II of the Covid-19 emergency |
Fiori Giancarla, Trovato Cristina, Staiano Teresa, Magarotto Andrea, Stigliano Vittoria, Masci Enzo, Ciuffi Mario, Rossi Giovanni Battista, Fantin Alberto, Realdon Stefano, Ugenti Ippazio, Cannizzaro Renato |
| 159 |
[GO] |
2020―Jun―15 |
COVID-19-related thrombotic microangiopathy in a cirrhotic patient |
A. Airoldi, G. Perricone, S. De Nicola, C. Molisano, P. Tarsia, L.S. Belli |
| 160 |
[GO] |
2020―Jun―13 |
LOW FREQUENCY OF COVID-19 IN INFLAMMATORY BOWEL DISEASES |
Irene Marafini, Silvia Salvatori, Giorgia Sena, Emma Calabrese, Livia Biancone, Giovanni Monteleone |
| 161 |
[GO] |
2020―Jun―13 |
THE FORGOTTEN VICTIMS OF THE COVID-19 PANDEMIC |
Harold Benites-Goñi, Jéssica Alférez-Andía, Fernando Barreda-Bolaños |
| 162 |
[GO] |
2020―Jun―13 |
Medical care of atrophic gastritis patients during COVID-19 pandemic: results of telemedicine in a referral center |
Gianluca Esposito, Emanuele Dilaghi, Gloria Galli, Laura Conti, Bruno Annibale, Edith Lahner |
| 163 |
[GO] |
2020―Jun―13 |
LIGHTS AND SHADOWS OF SARS-CoV-2 INFECTION RISK ASSESSMENT IN ENDOSCOPY |
Roberto Grassia, Sophie Testa, Annalisa De Silvestri, Andrea Drago, Fabrizio Cereatti, Clara Benedetta Conti |
| 164 |
[GO] |
2020―Jun―13 |
Impact of SARS-CoV-2 on a high volume endoscopy centre in Italy |
Ivo Boškoski, Silvia Pecere, Vincenzo Bove, Federico Barbaro, Vincenzo Perri, Guido Costamagna |
| 165 |
[GO] |
2020―Jun―11 |
Ref. No. DLD-20-852: Onset of ulcerative colitis during SARS-Cov-2 infection |
Emma Calabrese, Francesca Zorzi, Giovanni Monteleone, Giovanna Del Vecchio Blanco |
| 166 |
[GO] |
2020―Jun―10 |
Intestinal ischemia in the COVID-19 era |
Lorenzo Norsa, Clarissa Valle, Denise Morotti, Bonaffini Pietro Andrea, Amedeo Indriolo, Sonzogni Aurelio |
| 167 |
[GO] |
2020―Mai―29 |
Fecal Calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak. |
Dr Cherradi Younes |
| 168 |
[GO] |
2020―Mai―29 |
Will the COVID-19 pandemic affect HCV disease burden? |
Loreta A. Kondili, Andrea Marcellusi, Stephen Ryder, Antonio Craxì |
| 169 |
[GO] |
2020―Mai―26 |
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns |
Stefano Festa, Annalisa Aratari, Fabiola De Biasio, Federica Fascì-Spurio, Claudio Papi |
| 170 |
[GO] |
2020―Mai―23 |
Negative-pressure box under continuous suction for shielding against aerosols produced by patients with COVID-19 during abdominal ultrasound-guided intervention |
Joji Tani, Hideki Kobara, Noriko Nishiyama, Tsutomu Masaki |
| 171 |
[GO] |
2020―Mai―23 |
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: a European Survey |
Giovanni Marasco, Olga Maria Nardone, Marcello Maida, Ivo Boskoski, Luca Pastorelli, Franco Scaldaferri |
| 172 |
[GO] |
2020―Mai―19 |
Systematic analysis of acute liver injury during SARS-CoV-2 infection |
Jose D. Debes, Chimaobi M. Anugwom, Elizabeth S. Aby |
| 173 |
[GO] |
2020―Mai―16 |
Redesign of a GI endoscopy unit during the COVID-19 emergency: A practical model |
Vincenzo Cennamo, Marco Bassi, Stefano Landi, Pasquale Apolito, Stefania Ghersi, Emanuele Dabizzi, Anna Maria Polifemo, Giuseppe Gizzi, Stefano Guicciardi, Giuseppe Indelicato, Carmelo Cascone, Daniele Tovoli, Fabio Tumietto, Pierluigi Viale, Elio Jovine, Alessandro Repici |
| 174 |
[GO] |
2020―Mai―16 |
A negative fallout of COVID-19 lockdown in Italy: life-threatening delay in the diagnosis of celiac disease |
Giulia N. Catassi, Martina Vallorani, Federica Cerioni, Elena Lionetti, Carlo Catassi |
| 175 |
[GO] |
2020―Mai―16 |
ANALYSIS OF PATIENTS ATTITUDE TO UNDERGO URGENT ENDOSCOPIC PROCEDURES DURING COVID-19 OUTBREAK IN ITALY |
E Armellini, A Repici, C Alvisi, M Dinelli, P Gambitta, G Manes, M Mutignani, S Orlando, F Radaelli, R Salerno, G Venezia, C Verna, R Penagini, F Pace |
| 176 |
[GO] |
2020―Mai―16 |
“Impact of the COVID-19 pandemic on Gastroenterology Divisions in Italy: a national survey” |
M. Maida, S. Sferrazza, E. Savarino, L. Ricciardiello, A. Repici, F. Morisco, M. Furnari, L. Fuccio, G.C. Morreale, A. Vitello, P. Burra, S. Marchi, B. Annibale, A. Benedetti, D. Alvaro, G. Ianiro |
| 177 |
[GO] |
2020―Mai―16 |
COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine |
Monica Siniscalchi, Fabiana Zingone, Edoardo Vincenzo Savarino, Anna D'Odorico, Carolina Ciacci |
| 178 |
[GO] |
2020―Mai―15 |
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR) |
Frederic Di Fiore, Olivier Bouché, Come Lepage, David Sefrioui, Alice Gangloff, Lilian Schwarz, Jean Jacques Tuech, Thomas Aparicio, Thierry Lecomte, Camille Boulagnon-Rombi, Astrid Lièvre, Sylvain Manfredi, Jean Marc Phelip, Pierre Michel |
| 179 |
[GO] |
2020―Mai―15 |
No Need of Transforming Gastroenterology Units to COVID Units at the Time of SARS-COV2 Infection - A Single-Center Analysis from Northern Italy |
Fabiana Zingone, Cesare Casadei, Fabio Farinati, Edoardo Savarino |
| 180 |
[GO] |
2020―Mai―08 |
Clinical characteristics of Coronavirus Disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases |
Hu Zhang, Yu-Sheng Liao, Jing Gong, Jing Liu, Xi Xia, Heng Zhang |
| 181 |
[GO] |
2020―Mai―06 |
A WEB-BASED GROUP TREATMENT FOR PATIENTS WITH ALCOHOLIC LIVER DISEASES AT THE TIME OF THE COVID-19 PANDEMIC |
Matteo Massimo Bossi, Manuel Tufoni, Giacomo Zaccherini, Agnese Antognoli, Marco Domenicali, Paolo Caraceni |
| 182 |
[GO] |
2020―Apr―29 |
SARS-CoV-2 and gastrointestinal tract: the dark side of the pandemic |
Roberto Grassia, Sophie Testa, Angelo Pan, Clara Benedetta Conti |
| 183 |
[GO] |
2020―Apr―27 |
Endoscopy during the Covid-19 outbreak: experience and recommendations from a single center in a high-incidence scenario |
Luca Elli, Alessandro Rimondi, Lucia Scaramella, Matilde Topa, Maurizio Vecchi, Davide Mangioni, Andrea Gori, Roberto Penagini |
| 184 |
[GO] |
2020―Apr―18 |
EUS-guided gallbladder drainage during a pandemic crisis - How the COVID-19 outbreak could impact interventional endoscopy |
Dr. Andrea Lisotti, Prof. Pietro Fusaroli |
| 185 |
[GO] |
2020―Apr―10 |
Screening for Active COVID-19 Infection and Immunization Status Prior to Biologic Therapy in IBD Patients at the Time of the Pandemic Outbreak |
Fabiana Zingone, Andrea Buda, Edoardo Vincenzo Savarino |
| 186 |
[GO] |
2020―Apr―08 |
Covid-19 and cancer patients: Choosing wisely is the key |
Renato Cannizzaro, Fabio Puglisi |
| 187 |
[GO] |
2020―Apr―08 |
Challenges in paediatric inflammatory bowel diseases in the COVID-19 time |
Valeria Dipasquale, Salvatore Cucchiara, Massimo Martinelli, Erasmo Miele, Marina Aloi, Claudio Romano |
|
